<?xml version="1.0" encoding="UTF-8"?>
<p>The following variables were studied: donor age and HCV status, recipient age and sex, duration of hemodialysis, pre- and post-transplantation liver status, HBV and HIV co-infection as well as delayed graft function, immunosuppression, frequency of biopsy-proven rejection (acute and chronic, and cellular and humoral), mean serum creatinine at one year, frequency of new-onset diabetes after transplantation (NODAT), bacteremia, cytomegalovirus infection, cardiovascular events, neoplasia, patient and graft survival in both groupsâ€”with and without HCV infection. </p>
